BioVaxys and SpayVac-for-Wildlife Expand License Agreement to Include Aquaculture Market

BioVaxys and SpayVac-for-Wildlife Expand License Agreement to Include Aquaculture Market

BioVaxys Technology Corp. and SpayVac-for-Wildlife have significantly broadened their collaborative efforts by expanding their existing license agreement to encompass commercial aquaculture and farm-raised fish markets. This strategic expansion substantially increases the potential global revenue opportunities for their innovative fertility-control vaccine technology. The newly expanded agreement allows SpayVac to develop and market no-booster f…

BioVaxys And SpayVac For Wildlife, Inc. Expand License Agreement Into Commercial Aquaculture - Canadian Manufacturing

VANCOUVER and MADISON — BioVaxys Technology Corp. and SpayVac for Wildlife, Inc. jointly announce an expansion of the Fields of Use in the current License Agreement to include commercial aquaculture, plus the farm-raised fish market. With this expansion in the Fields of Use, SpayVac-for-Wildlife’s markets now include its no-booster fertility-control vaccines for aquaculture as well as overabundant feral/wild/invasive animals, and select producti…

Minister meets Irish aquaculture leaders to discuss licensing delays

Irish aquaculture leaders meet with Minister to discuss licensing and sector challenges IFA Aquaculture representatives met last week with Irish Minister of State Timmy Dooley during his visit to Killybegs Harbour Centre to discuss licensing renewals and recent biological challenges affecting the sector. IFA Aquaculture Executive Teresa Morrissey and Mowi Ireland operations director and Committee [...]